[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Da Porto et al., 2022 - Google Patents

Nutritional supplementation on wound healing in diabetic foot: What is known and what is new?

Da Porto et al., 2022

View HTML
Document ID
4513252731693438117
Author
Da Porto A
Miranda C
Brosolo G
Zanette G
Michelli A
Da Ros R
Publication year
Publication venue
World Journal of Diabetes

External Links

Snippet

Non-healing diabetic foot ulcers (DFU) are the most notable and striking complications of diabetes mellitus. More than 25% of nonhealing DFU can ultimately lead to amputation of the lower extremity within 6-18 mo after the first manifestation of the wound. Although wound …
Continue reading at www.ncbi.nlm.nih.gov (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER, CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using micro-organisms or enzymes

Similar Documents

Publication Publication Date Title
Smith-Ryan et al. Nutritional considerations and strategies to facilitate injury recovery and rehabilitation
Da Porto et al. Nutritional supplementation on wound healing in diabetic foot: What is known and what is new?
Hackam et al. Necrotizing enterocolitis: Pathophysiology from a historical context
Massironi et al. Nutritional deficiencies in inflammatory bowel disease: therapeutic approaches
Bischoff et al. ESPEN practical guideline: Clinical Nutrition in inflammatory bowel disease
Larussa et al. Potential role of nutraceutical compounds in inflammatory bowel disease
Martin et al. Review of infant feeding: key features of breast milk and infant formula
Klek et al. Four-week parenteral nutrition using a third generation lipid emulsion (SMOFlipid)–a double-blind, randomised, multicentre study in adults
Das Long-chain polyunsaturated fatty acids in the growth and development of the brain and memory
Anez-Bustillos et al. Redefining essential fatty acids in the era of novel intravenous lipid emulsions
Hwang et al. Popular exclusionary diets for inflammatory bowel disease: the search for a dietary culprit
Berti et al. Early-life nutritional exposures and lifelong health: immediate and long-lasting impacts of probiotics, vitamin D, and breastfeeding
Marques et al. Gut microbiota modulation and implications for host health: Dietary strategies to influence the gut–brain axis
Kane et al. Routine supplementation of Lactobacillus rhamnosus GG and risk of necrotizing enterocolitis in very low birth weight infants
Kromhout et al. The confusion about dietary fatty acids recommendations for CHD prevention
Hsiao et al. Early optimal nutrition improves neurodevelopmental outcomes for very preterm infants
Lilja et al. Prevention and reversal of intestinal failure–associated liver disease in premature infants with short bowel syndrome using intravenous fish oil in combination with omega-6/9 lipid emulsions
Barnard et al. Children and adults should avoid consuming animal products to reduce risk for chronic disease: YES
Stephenson et al. Low linoleic acid foods with added DHA given to Malawian children with severe acute malnutrition improve cognition: a randomized, triple-blinded, controlled clinical trial
Leaf Introducing enteral feeds in the high-risk preterm infant
Garg et al. Role of DHA, ARA, & phospholipids in brain development: An Indian perspective
Shafiee et al. Anti-inflammatory diet and inflammatory bowel disease: what clinicians and patients should know?
Aljewicz et al. The effect of probiotic Lactobacillus rhamnosus HN001 on the in vitro availability of minerals from cheeses and cheese-like products
Hardin et al. Diet-induced chronic syndrome, metabolically transformed trimethylamine-N-oxide, and the cardiovascular functions
Le et al. Innovative parenteral and enteral nutrition therapy for intestinal failure